Filing Details

Accession Number:
0001213900-23-067446
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-15 08:00:17
Reporting Period:
2023-08-15
Accepted Time:
2023-08-15 08:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733413 Tff Pharmaceuticals Inc. TFFP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555563 F Harlan Weisman 1751 River Run, Suite 400
Fort Worth TX 76107
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-15 600,000 $0.25 814,615 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.